Results 141 to 150 of about 138,725 (257)

Delgocitinib in dermatology: a topical pan-JAK inhibitor for chronic hand eczema and atopic dermatitis. [PDF]

Ann Med Surg (Lond)
Haider E, Tanveer L, Usman Iqbal M, Taj J, Tague C.   +4 more
europepmc   +1 more source

Formononetin ameliorates high glucose‑induced endothelial dysfunction by inhibiting the JAK/STAT signaling pathway

, 2019
Zhen Zhou, Xinjian Zhou, Youhong Dong, Mingyi Li, Yancheng Xu   +4 more
openalex   +2 more sources

The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies. [PDF]

Blood Lymphat Cancer
Reynolds SB, Komrokji R, Kuykendall AT.
europepmc   +1 more source

Novel <i>USP18</i> mutations lead to severe interferonopathy responsive to JAK inhibitor. [PDF]

Front Immunol
Sun X, Li M, Dou Y, Wang Q, Lai J, Zhu J, Zhou Q, Yu X.   +7 more
europepmc   +1 more source

Characterization of Second-Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry. [PDF]

ACR Open Rheumatol
Baker JF, Mizelle KV, Saikali W, Moore PC, Kang HJ, Gruben D, Shelbaya A, Stockert L, O'Brien J.   +8 more
europepmc   +1 more source

Langerhans Cell Modulation in Atopic Dermatitis Is TLR2/SOCS1-Dependent and JAK Inhibitor-Sensitive. [PDF]

Allergy
Deng Y, Leib N, Schnautz S, Benfadal S, Oldenburg J, Bieber T, Herrmann N.   +6 more
europepmc   +1 more source

Successful Treatment of Granulomatous Rosacea by JAK Inhibitor Abrocitinib: A Case Report. [PDF]

Clin Cosmet Investig Dermatol, 2023
Ren M, Yang X, Teng Y, Lu W, Ding Y, Tao X.   +5 more
europepmc   +1 more source

The transmembrane domain of the ASFV p22 is essential for inhibiting the activation of the JAK-STAT signaling pathway.

Haojie Ren (9353596), Yanjin Wang (1375503), Lian-Feng Li (14680123), Lan-Fang Shi (21728677), Yu-He Ma (21728680), Jun-Hao Fan (21728683), Xiao-Ya Pan (21728686), Han-Cheng Shao (21728689), Yuhang Zhang (3144870), Shichong Han (665820), Bo Wan (212083), Hua-Ji Qiu (3967025), Gai-Ping Zhang (8616999), Su Li (294188), Wen-Rui He (21728692)   +14 more
openalex   +1 more source

Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors [PDF]

, 2019
Anja Meyer, Paula S. Wittekind, Konstantin Kotschenreuther, Joanna Schiller, Julia von Tresckow, Thomas H. Haak, David M. Kofler   +6 more
openalex   +1 more source

Pharmacokinetic Monitoring of JAK Inhibitor and Tacrolimus for Safe and Effective Management of Graft-Versus-Host Disease After Pediatric Liver Transplantation. [PDF]

Pediatr Transplant
Sawada K, Khandelwal P, Davies SM, Crooker A, Mizuno T, Asai A.   +5 more
europepmc   +1 more source